Log in to save to my catalogue

Anti-leukemia activity of chaetocin via death receptor-dependent apoptosis and dual modulation of th...

Anti-leukemia activity of chaetocin via death receptor-dependent apoptosis and dual modulation of th...

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_proquest_miscellaneous_993907904

Anti-leukemia activity of chaetocin via death receptor-dependent apoptosis and dual modulation of the histone methyl-transferase SUV39H1

About this item

Full title

Anti-leukemia activity of chaetocin via death receptor-dependent apoptosis and dual modulation of the histone methyl-transferase SUV39H1

Publisher

London: Nature Publishing Group UK

Journal title

Leukemia, 2012-04, Vol.26 (4), p.662-674

Language

English

Formats

Publication information

Publisher

London: Nature Publishing Group UK

More information

Scope and Contents

Contents

Epigenetic deregulation is involved in acute myeloid leukemia (AML) pathogenesis and epigenetic targeting drugs are in clinical trial. Since the first results with histone-deacetylase inhibitors in AML are controversial, novel single and combined treatments need to be explored. It is tempting to combine chromatin-targeting drugs. SUV39H1, the main...

Alternative Titles

Full title

Anti-leukemia activity of chaetocin via death receptor-dependent apoptosis and dual modulation of the histone methyl-transferase SUV39H1

Identifiers

Primary Identifiers

Record Identifier

TN_cdi_proquest_miscellaneous_993907904

Permalink

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_proquest_miscellaneous_993907904

Other Identifiers

ISSN

0887-6924

E-ISSN

1476-5551

DOI

10.1038/leu.2011.271

How to access this item